Advertisement
Research Article Free access | 10.1172/JCI117088
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
Find articles by Goss, J. in: JCI | PubMed | Google Scholar
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
Find articles by Finke, E. in: JCI | PubMed | Google Scholar
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
Find articles by Flye, M. in: JCI | PubMed | Google Scholar
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
Find articles by Lacy, P. in: JCI | PubMed | Google Scholar
Published March 1, 1994 - More info
Streptozotocin-induced, diabetic mice (C57BL/6) were preimmunized by injecting 25 low temperature, cultured Wistar-Furth (WF) rat islets into the portal vein, and the recipients received one injection of mouse and rat antilymphocyte sera. 3 wk later, fresh WF islets were transplanted under the kidney capsule of the preimmunized recipients, and normoglycemia was maintained in all 13 recipients for 60 d. Removal of the grafts at 60 d returned the mice to a diabetic state. Transplants of fresh WF islets under the kidney capsule without pretreatment of the recipients had a mean survival time of 16.5 +/- 2.5 d. These findings demonstrate that immune unresponsiveness can be achieved across a concordant, islet xenograft barrier within 3 wk after intrahepatic preimmunization with a small number of donor rat islets and transient immunosuppression with antilymphocyte sera.
Click on an image below to see the page. View PDF of the complete article